FeelBetter, a machine learning-enabled medication-management platform centered on polypharmacy, introduced it secured $5.9 million in funding led by Firstime Ventures and Shoni Well being Ventures.
Random Forest VC, The Group Ventures, and current FeelBetter investor Triventures additionally participated within the spherical.
The newest spherical brings the corporate’s complete elevate to $8 million.
WHAT IT DOES
FeelBetter focuses on the polypharmacy paradigm, the simultaneous use of a number of medication by one affected person for a number of situations. The corporate’s AI-enabled platform analyzes knowledge on a affected person’s well being standing and medical historical past, pharmacology and scientific tips to look at the connections between the completely different sources to enhance a affected person’s treatment routine.
The corporate will use the funds to develop its attain and advance its platform.
« At a time when traders are particularly selective in regards to the sorts of bets they’re taking, this spherical and vote of confidence from the world-class groups at Firstime Ventures, Shoni Well being Ventures, Random Forest VC, Triventures, and The Enterprise Group, in addition to angel traders, validates the necessity for and potential of our pharmaco-clinical intelligence as an answer for the rising, world well being problem posed by suboptimal treatment administration, » Liat Primor, FeelBetter’s CEO and cofounder stated in a press release.
Different firms within the treatment administration house embody Arine, which affords knowledge analytics instruments for treatment administration, and retail big Walmart, which bought digital treatment administration firm CareZone‘s tech platform, patents and mental property in 2020.